A Prospective, Single-center, Blinded, Randomized, Split-face Study Evaluating the Spread of PrabotulinumtoxinA-xvfs Versus OnabotulinumtoxinA in the Treatment of Forehead Rhytides
Ten subjects will be enrolled in the study. Each subject will have their left and right forehead randomly assigned to receive 4 units of PrabotulinumtoxinA-xvfs or OnabotulinumtoxinA. Subjects will be reassessed at 2 weeks for evaluation of rhytide diminution around each injection point to assess relative diffusion of each drug in the forehead.
100 Clinical Results associated with Lupo Center for Aesthetic and General Dermatology
0 Patents (Medical) associated with Lupo Center for Aesthetic and General Dermatology
100 Deals associated with Lupo Center for Aesthetic and General Dermatology
100 Translational Medicine associated with Lupo Center for Aesthetic and General Dermatology